MSB 1.49% $1.02 mesoblast limited

Inflammation - evolution - stem cells - F22 Raptor, page-5

  1. 26 Posts.
    lightbulb Created with Sketch. 24
    Excellent analysis and commentary - just the sort of thing that MSB should be disseminating on their own website. Great to see rather than just more moaning about the share price.

    Of course it is human to get frustrated but MSB management are walking a tight line - having to deal with the burn rate of multiple late stage clinical trials vs letting a big pharma in too cheaply. I hope they keep their nerve.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.